Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

Donald Trump is executing a shock-and-awe strategy, burying the public in a smoky cloud of flamboyant proposals. Some, like ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

The North Carolina Rural Economic Development Center has received a grant of $6.38 million from Lilly Endowment Inc. through its Ministry in Rural Areas and Small Towns Initiative.

Amazon and Google parent Alphabet are set to report earnings, along with other tech companies including AI darling Palantir, and chipmaker Advanced Micro Devices. Pharmaceutical firms Novo Nordisk, ...

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

"Charlie & Lilly's birthday frenzy‚ pure beagle chaos! Wild Wonders brings you closer to the fascinating world of animals, pets, and wildlife! Dive into heartwarming pet stories, thrilling wildlife ...

Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.

President Donald Trump is executing a shock and awe strategy, burying the public in a smoky cloud of flamboyant proposals.